# The Ensign Group Inc. (ENSG) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Equipment & Supplies. Price $170.79, market value $10.0 billion.

## Valuation
- **P/E (trailing): 26.7×** (5-yr avg 26.9×, 3-yr avg 28.8×). The Ensign Group Inc. trades at 26.7× trailing earnings, close to its own five-year average of 26.9×. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 20.0×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 1.42**. A PEG of 1.42 is in the range usually read as fairly priced for its growth.
- **Price / sales: 1.8×**. Each dollar of revenue is priced at 1.8×.
- **Price / book: 4.0×**. The shares trade at 4.0× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 16.5×**. Enterprise value is 16.5× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Earnings yield: 3.7%**. The inverse of the P/E: 3.7% of the price is earned each year.

## Profitability
- **Operating margin: 8.6%**. 8.6% of revenue is left after running the business.
- **Net margin: 6.8%**. 6.8% of each dollar of sales reaches the bottom line.
- **Return on equity: 15.4%**. 15.4% on shareholders' equity is solid.
- **Return on invested capital: 19.7%**. Return on all capital, debt included, is 19.7%: comfortably above what that capital costs.
- **Return on assets: 6.9%**. Each dollar of assets produces 6.9% of profit.

## Growth
- **Revenue growth (1 yr): 18.8%** (3-yr 18.5%/yr, 5-yr 16.1%/yr). Revenue grew 18.8% over the last year, against 16.1% a year compounded over five years.
- **EPS growth (1 yr): 14.1%** (3-yr 13.9%/yr, 5-yr 13.8%/yr). Earnings per share rose 14.1%, roughly in step with revenue.

## Financial health
- **Debt to equity: 0.06**. Debt is 0.06 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. The Ensign Group Inc. holds more cash than debt.
- **Altman Z-score: 3.60**. A Z-score of 3.60 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 0.15%** ($0.26 per share, trailing). The Ensign Group Inc. yields 0.15%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 4%**. 4% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 19**. 19 straight years of increases, a record that survived at least one recession.
- **Dividend growth (5 yr): 4.6%/yr** (1-yr 4.5%). The dividend has grown 4.6% a year over five years.

## Price and momentum
- **Total return (1 yr): -1.1%** (YTD -1.9%, 3-mo 0.3%). The shares are down 1.1% over twelve months including dividends.
- **From 52-week high: -21.7%** (20.6% above the low). Trading 22% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 37**. An RSI of 37 is neutral.
- **Beta (1 yr): -0.01** (volatility 28%). Beta of -0.01 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ENSG · Page: https://foliofundamentals.com/stocks/ensg

Not investment advice.